AmerisourceBergen Corporation
ABC
NYSE
Last Updated: 6/9/2023 8:00:01 PM
High
Low
About AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.AmerisourceBergen Corporation Company Details
CEO: Mr. Steven H. Collis
Country: US
Industry: Medical Distribution
Website: https://www.amerisourcebergen.com
Exchange: New York Stock Exchange
IPO\Launch Date: 1993-12-16
AmerisourceBergen Corporation Company Executive Details
Mr. John G. Chou
Executive Vice President and Special Advisor to the Chairman & Chief Executive Officer
Bennett S. Murphy
Senior Vice President of Investor Relations
Ms. Gina K. Clark
Executive Vice President and Chief Communications & Admin. Officer
Mr. Steven H. Collis
Chairman, Pres & Chief Executive Officer
Mr. James F. Cleary Jr.
Executive Vice President & Chief Financial Officer
AmerisourceBergen Corporation Latest News
Why Is AmerisourceBergen (ABC) Up 2% Since Last Earnings Report?
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
Published on: 2023-06-01 12:35:47
Impact on Symbol / Company: ABC
View News
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Published on: 2023-05-29 11:50:06
Impact on Symbol / Company: ABC
View News
Walgreens Sells AmerisourceBergen Shares To Raise $694 Million To Pay Down Debt
Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes."
Published on: 2023-05-12 11:34:47
Impact on Symbol / Company: ABC
View News
Should Value Investors Buy AmerisourceBergen (ABC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Published on: 2023-05-05 11:23:42
Impact on Symbol / Company: ABC
View News
3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)
AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Published on: 2023-05-04 14:26:15
Impact on Symbol / Company: ABC
View News
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.
Published on: 2023-05-03 11:27:24
Impact on Symbol / Company: ABC
View News
AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View
AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.
Published on: 2023-05-02 16:51:13
Impact on Symbol / Company: ABC
View News
AmerisourceBergen (ABC) Beats Q2 Earnings and Revenue Estimates
AmerisourceBergen (ABC) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.22 per share a year ago.
Published on: 2023-05-02 09:08:21
Impact on Symbol / Company: ABC
View News
AmerisourceBergen stock pops premarket after earnings blow past estimates
AmerisourceBergen Corp.'s stock ABC rose 0.8% premarket Tuesday, after the pharmaceutical services company's fiscal second-quarter earnings blew past estimates. The company had net income of $435.4 million, or $2.13 a share, for the quarter to March 31, down from $548.0 million, or $2.59 a share, in the year-earlier period.
Published on: 2023-05-02 07:06:00
Impact on Symbol / Company: ABC
View News
AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?
AmerisourceBergen's (ABC) fiscal 2023 second-quarter results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
Published on: 2023-04-26 12:11:31
Impact on Symbol / Company: ABC
View News
AmerisourceBergen's (ABC) New JV to Boost Oncology Care
AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.
Published on: 2023-04-21 12:56:37
Impact on Symbol / Company: ABC
View News
TPG, AmerisourceBergen to OneOncology in a deal that values the oncology practices network at $2.1 billion
Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is expected to occur by the end of September 2023, TPG will own a majority of OneOncology, and AmerisourceBergen will pay $685 million in cash for a 35% stake.
Published on: 2023-04-20 08:43:00
Impact on Symbol / Company: ABC
View News
Grow your Money
We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures
Services we Offer
We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others
Live Market Data
We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you